PHAT Phathom Pharmaceuticals, Inc.
$6.28▲ +4.84%
Healthcare
Other
After hours
$6.45▲ +2.71%
Oct 28, 7:54 PM ET
Volume 2.08M
Avg Volume (10D) 1.66M
Key Metrics & Fundamentals
Market Cap
$508.06M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.02 - 18.31
% vs 50 MA
-19.08%
% vs 200 MA
-40.39%
RSI-14
39.0
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.58
Free Cash Flow
-$1.97M
Gross Rev
$74.27M
Gross Profit
$59.18M
EBITDA
-$2.37M
COGS
$15.10M
Operating Exp
$63.14M
Operating Income
-$3.97M
EBIT
-$3.97M
Pretax Income
-$17.58M
Net Income
-$17.58M
EPS (Diluted)
-0.21
Price & Volume History
Loading chart…
Recent News
Phathom Pharmaceuticals Provides Update on FDA Litigation
GlobeNewswire · Oct 26, 2026 4:00 AM ET
PHAT Stock Eyes Worst Day In Nearly Two Years After Generic Drug Maker Challenges Key Drug’s Exclusivity
Stocktwits · Oct 23, 2026 1:45 PM ET
Phathom Pharmaceuticals Faces Legal Challenge Over VOQUEZNA Exclusivity
MT Newswires · Oct 23, 2026 5:39 AM ET
Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA
GlobeNewswire · Oct 23, 2026 4:00 AM ET
Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
GlobeNewswire · Oct 19, 2026 8:00 AM ET
Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA® (vonoprazan) at ACG 2026
GlobeNewswire · Oct 12, 2026 8:00 AM ET
Phathom Pharmaceuticals to Present New Data and Analyses for VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting
GlobeNewswire · Oct 8, 2026 8:00 AM ET
Phathom Pharmaceuticals Starts Registrational Phase 3 Voquezna Study
MT Newswires · Sep 29, 2026 9:06 AM ET
Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD
GlobeNewswire · Sep 29, 2026 8:00 AM ET
PHAT Stock Falls 7% As Leerink Sees Little Near-Term Upside — CEO Plays Down Upcoming Rival
Stocktwits · Sep 9, 2026 1:26 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PHAT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.